Postgraduate Programme in Navigating Immunotherapy
Duration: 6 weeks
ICGP and NMBI
€Fully funded by MSD for Irish HCWs
The comprehensive online educational programme, developed by iheed, supported by MSD and accredited by professional bodies, is designed to address the educational gap in immuno-oncology and immune- related adverse event (irAE) management.
Offered free of charge, the course focuses on best practices in the recognition and management of irAEs. Engaging and interactive, the programme combines self-paced e-learning, discussion forums, and live workshops facilitated by subject experts
Immunotherapy represents a groundbreaking approach to cancer treatment, utilizing the body’s immune system to target and eliminate cancer cells. This innovative therapy offers promising outcomes for various cancer types and has become an increasingly significant component of modern cancer care. As immunotherapy continues to evolve, understanding its mechanisms, applications, and potential complications becomes crucial for healthcare professionals to provide effective patient care and support.
While effective, Immunotherapy can sometimes lead to immune-related adverse events (irAEs) due to the immune system’s heightened activity. Managing irAEs is essential to ensure patient safety and treatment efficacy. Effective management involves early identification, prompt intervention, and continuous monitoring.
A world-class online learning experience
This online interactive programme will be delivered fully online through a stimulating learning environment that has:
Rich engaging and interactive content designed to maximise interaction
Tutor moderated discussion forums
Live weekly online tutorials
Interactive case based learning
Access to an extensive online library, journals and formularies
Who is this programme for?
This programme targets General Practitioners, Non-Consultant Hospital Doctors, Nurses, and Pharmacists who are not oncology specialists but are involved in the care of cancer patients undergoing immunotherapy.
Upon completion of the programme, participants will be equipped with a solid understanding of immunotherapy treatments and a greater ability to identify irAEs effectively.
It aims to empower these healthcare professionals with the knowledge and skills needed to effectively identify and respond to irAEs, improving patient care and fostering interdisciplinary collaboration.